'On consolidated basis
Quarter ended September 2025 compared with Quarter ended September 2024.
Net sales (including other operating income) of Natco Pharma has declined 0.59% to Rs 1363 crore. Sales of Pharmaceutical segment has gone down 3.37% to Rs 1,310.50 crore (accounting for 96.15% of total sales). Sales of Agro Chemical segment has gone up 252.35% to Rs 52.50 crore (accounting for 3.85% of total sales).
Profit before interest, tax and other unallocable items (PBIT) has slumped 23.77% to Rs 626.80 crore. PBIT of Pharmaceutical segment fell 25.14% to Rs 633.40 crore (accounting for 101.05% of total PBIT). PBIT of Agro Chemical segment rose 72.27% to Rs -6.60 crore (accounting for -1.05% of total PBIT).
PBIT margin of Pharmaceutical segment fell from 62.39% to 48.33%. PBIT margin of Agro Chemical segment rose from negative 159.73% to negative 12.57%. Ove...
Pleaselogin & subscribe to view the full report.
More Reports
|
|